Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: A pilot study

  • Carolyn D Britten1Email author,
  • Antoinette S Gomes2,
  • Zev A Wainberg1,
  • David Elashoff3,
  • Rafael Amado1,
  • Yan Xin4,
  • Ronald W Busuttil5,
  • Dennis J Slamon1 and
  • Richard S Finn1
BMC Cancer201212:16

DOI: 10.1186/1471-2407-12-16

Received: 28 June 2011

Accepted: 14 January 2012

Published: 14 January 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
28 Jun 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
2 Sep 2011 Reviewed Reviewer Report - Henning Wege
5 Sep 2011 Reviewed Reviewer Report - Fabio Farinati
9 Nov 2011 Author responded Author comments - Carolyn Britten
Resubmission - Version 3
9 Nov 2011 Submitted Manuscript version 3
Publishing
14 Jan 2012 Editorially accepted
14 Jan 2012 Article published 10.1186/1471-2407-12-16

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles
(2)
Departments of Medicine and Radiologic Science, David Geffen School of Medicine at the University of California, Los Angeles, Ronald Reagan Medical Center
(3)
Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles
(4)
Genentech, Inc
(5)
Department of Surgery, Chairman's Office, David Geffen School of Medicine at the University of California, Los Angeles

Advertisement